Current Issue Previous Issues Published Ahead-of-Print CME Subjects Timely Topics Translations Podcasts For Authors Journal Info
Skip Navigation LinksHome > February 2012 - Volume 114 - Issue 2 > Evolution of the Extraglottic Airway: A Review of Its Histo...
Anesthesia & Analgesia:
doi: 10.1213/ANE.0b013e31823b6748
Patient Safety: Review Article

Evolution of the Extraglottic Airway: A Review of Its History, Applications, and Practical Tips for Success

Hernandez, Michael R. MD*; Klock, P. Allan Jr. MD*; Ovassapian, Adranik MD*,†

Free Access
Supplemental Author Material
Article Outline
Collapse Box

Author Information

From the *Department of Anesthesia and Critical Care, University of Chicago Hospitals, Chicago, IL. Deceased.

Conflicts of interest: see Disclosures at end of the article.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site www.anesthesia-analgesia.org.

Reprints will not be available from the authors.

Address correspondence to Michael R. Hernandez, MD, The University of Chicago Medical Center, Room M252L. Department of Anesthesia and Critical Care, 5841 South Maryland Ave., MC4028, Chicago, IL 60637. Address e-mail to mhernandez@dacc.uchicago.edu.

Accepted October 4, 2011

Published ahead of print December 16, 2011

Collapse Box

Abstract

The development of the laryngeal mask airway in 1981 was an important first step toward widespread use and acceptance of the extraglottic airway (EGA). The term extraglottic is used in this review to encompass those airways that do not violate the larynx, in addition to those with a supraglottic position. Although the term extraglottic may be broad and include airways such as tracheostomy tubes, the term supraglottic does not describe a large number of devices with subglottic components and is too narrow for a discussion of modern devices. EGAs have flourished in practice, and now a wide variety of devices are available for an ever-expanding array of applications. In this review we attempt to clarify the current state of EGA devices new and old, and to illustrate their use in numerous settings. Particular attention is paid to the use of EGAs in special situations such as obstetric, pediatric, prehospital, and nontraditional “out of the operating room” settings. The role of the EGA in difficult airway management is discussed. EGA devices have saved countless lives because they facilitate ventilation when facemask ventilation and tracheal intubation were not possible. Traditionally, difficult airway management focused on successful tracheal intubation. The EGA has allowed a paradigm shift, changing the emphasis of difficult airway management from tracheal intubation to ventilation and oxygenation. EGA devices have proved to be useful adjuncts to tracheal intubation; in particular, the combination of EGA devices and fiberoptic guidance is a powerful technique for difficult airway management.

Despite their utility, EGAs do have disadvantages. For example, they typically do not provide the same protection from pulmonary aspiration of regurgitated gastric material as a cuffed tracheal tube. The risk of aspiration of gastric contents persists despite advances in EGA design that have sought to address the issue. The association between excessive EGA cuff pressure and potential morbidity is becoming increasingly recognized. The widespread success and adoption of the EGA into clinical practice has revolutionized airway management and anesthetic care. Although the role of EGAs is well established, the user must know each device's particular strengths and limitations and understand that limited data are available for guidance until a new device has been well studied.

The laryngeal mask airway (LMA; LMA North America, San Diego, CA) was one of the first extraglottic airways (EGA) invented by Dr. Archie Brain in 1981. It became commercially available in the United Kingdom in 1988 and in the United States in 1991. The LMA Classic (cLMA) received wide recognition in a short time and has had a major impact on anesthesia practice and airway management. Publication of thousands of peer-reviewed articles, book chapters, and textbooks testifies to the success of the LMA as an extraglottic device. Other individuals and manufacturers later introduced similar airway devices.

Despite significant literature detailing the use of EGAs, the constant evolution in device design encourages the clinical application of the LMA outside the traditional operating room (OR) suite. This review attempts not only to describe some of the history surrounding EGA devices, but also to understand how EGA use has evolved because of design modifications. EGAs have become much more than a simple airway device, and now enjoy a wide range of applications and indications, some of which were formerly relative contraindications.

The term supraglottic airway device is often used, but may not accurately describe airways that include periglottic components. Use of the term extraglottic airway device is perhaps more appropriate for this review, because it encompasses airways that do not violate the larynx. Although airway devices such as a tracheostomy tube may also be considered extraglottic, this review concerns itself only with devices that are inserted via the oropharynx for temporary airway management. A large number of recently introduced devices have complicated efforts to establish a consistent nomenclature and organizational framework for EGA devices1 (Table 1).

Table 1
Table 1
Image Tools

Despite a multitude of new devices introduced into the market, most devices aim to allow easy placement with predictable ventilation, minimize the chance of pulmonary aspiration, and to serve as an adjunct to tracheal intubation. This review aims to help the reader understand the similarities and differences among the numerous EGAs currently available and will present many EGA devices. EGAs are separated by manufacturer and then further subdivided by the chronology of market entry and/or special features.

Back to Top | Article Outline
LMAs
cLMA

One of the first EGAs, the cLMA (LMA North America, San Diego, CA), was studied extensively and used in >7000 patients by Dr. Archie Brain and his associate, Dr. Chandy Verghese, before its release for routine clinical use. The details of the development of LMAs are described by the inventor.2 Initial LMA prototypes were designed based on plaster casts of cadaveric airways. The use of the cLMA in anesthesia encouraged individuals and manufacturing companies to introduce other EGAs with many design modifications.

The cLMA is a reusable device made of silicone. Its disposable version, the LMA Unique (uLMA, LMA North America, Inc. San Diego, CA, USA), is made of polyvinylchloride (PVC). Both are latex-free and available in six sizes to fit infants to adults (Table 2; for additional details see Supplementary Table 2A, Supplementary Digital Content 1, http://links.lww.com/AA/A346). Both the cLMA and the uLMA have an elliptically shaped mask attached to a ventilation tube (Fig. 1). The mask has a cuff, a pilot tube, and balloon through which the cuff is inflated and maintenance of intracuff pressure is monitored. The proximal end of the shaft has a standard 15-mm adapter. The cLMA can be autoclaved and the manufacturer recommendations suggest that it may be reused up to 40 times. Two bars at the junction of the shaft and mask prevent the epiglottis from obstructing the ventilating lumen. In addition to its routine use in the OR during general anesthesia, the laryngeal mask is used for airway management outside of the OR and for management of difficult or failed intubation. It is included in the airway management algorithms of the American Society of Anesthesiologists (ASA) and the Difficult Airway Society of the United Kingdom.3,4

Table 2-a Extraglott...
Table 2-a Extraglott...
Image Tools
Figure 1
Figure 1
Image Tools

Originally, the cLMA was used in lieu of a facemask in anesthetized patients breathing spontaneously. Over the years, that practice has changed so that now the cLMA is also used with controlled ventilation in complicated operative procedures. Positive pressure ventilation via an LMA is possible only if the device provides an adequate airway seal. Quantification of an oropharyngeal seal or “leak” pressure is a common maneuver in the evaluation of LMAs, both to confirm suitable device function and for research purposes.5 Multiple techniques can be used to evaluate leak pressure.6 One technique uses increasingly positive pressure via the device to determine the level at which an audible leak is heard at the patient's mouth or during auscultation lateral to the thyroid cartilage. Other techniques include intraoral capnography to detect leakage of carbon dioxide from around the device at a given pressure, or the use of manometry to measure the pressure at equilibrium with the leak. All 4 techniques successfully measured the “leak” pressure in pediatric and adult patients after LMA placement.6,7

Table 2-b Extraglott...
Table 2-b Extraglott...
Image Tools
Table 2-c Extraglott...
Table 2-c Extraglott...
Image Tools
Table 2-d Extraglott...
Table 2-d Extraglott...
Image Tools

Before inserting the LMA, the cuff is deflated so that the edge is smooth and wrinkle-free with the tip deflected backward toward the convex side of the ventilation shaft. This method encourages the LMA to slide posterior to the epiglottis without deflecting it inferiorly over the glottic opening. The pharyngeal surface is lubricated generously; the lingual surface is lubricated lightly for smooth advancement. In the technique described by Dr. Brain (Fig. 2), the shaft of the LMA is held between index finger and thumb with the tip of the index finger at the junction of the mask and the tube. With the patient's head in the “sniffing” position, the nondominant hand is placed under the occiput, extending the head, while the dominant hand inserts the LMA into the mouth. With optimal technique, the LMA follows a path similar to a bolus of food that is about to be swallowed, traveling from the oropharynx against the hard palate to the soft palate, hypopharynx, and finally the proximal esophagus. The tip of the mask is pressed against the hard palate and advanced toward the larynx until resistance is felt. Manufacturer recommendations call for the mask to be inflated to an intracuff pressure of no >60 cm H2O (44 mm Hg). Intracuff pressure should be monitored, especially if nitrous oxide is being used, with its increased risk for expansion of the mask volume and associated injuries.8 When no muscle relaxant is used during insertion or throughout the anesthetic, an adequate depth of anesthesia is essential to prevent the contraction of pharyngeal and laryngeal muscles, which may interfere with proper positioning of the LMA. Occasionally, an LMA may be used to rescue a patient during a rapid sequence induction complicated by an inability to perform tracheal intubation and failed attempts to mask ventilate the patient. In this setting, the operator should remember that cricoid pressure may cause compression of the hypopharynx that may prevent the tip of the LMA from reaching a proper final position. As a result, it may be useful to relieve cricoid pressure temporarily to allow proper LMA positioning during insertion.9,10 The technique for placement of the uLMA is the same as the cLMA.

Figure 2
Figure 2
Image Tools

Properly positioned, the cLMA masks the glottis, maintains an open airway, and makes ventilation easy. The tip of the LMA sits posteriorly to the cricoid cartilage engaging the proximal esophageal sphincter, and the proximal end of the mask portion of the LMA lies against the base of the tongue. Satisfactory ventilation through the cLMA does not necessarily indicate proper positioning. Flexible bronchoscopy has shown that ventilation through a cLMA is acceptable with the device in less than perfect position.11 Proper placement of the LMA may be impeded when the tongue and epiglottis are pushed caudally or when the tonsils are enlarged; in such situations, the tip of the cLMA may press on the glottis causing partial or complete airway obstruction. The proximal part of the mask may obstruct the airway if the cLMA is positioned too deeply, or the mask may fold over on itself if excessive force is used during insertion.

Three factors contribute to the failure of proper placement: lack of experience of the operator, improper technique, and inadequate depth of anesthesia. Insertion of the cLMA during light anesthesia stimulates contraction of the pharyngeal wall, cricopharyngeus, and extrinsic laryngeal muscles. The cLMA may also become twisted during placement or if advanced too far when an undersized device is selected.

Back to Top | Article Outline
Advantages of the LMA

A 1995 meta-analysis of 858 publications identified several advantages of the cLMA over tracheal intubation.12 There were fewer changes in hemodynamic and intraocular pressure during placement and removal of the cLMA than during tracheal intubation and extubation. Awakening with a cLMA in place resulted in less coughing, bucking, and hemodynamic changes than awakening with an endotracheal tube in place. Laryngeal competence and mucociliary function were preserved and laryngeal trauma was less.13 The cLMA can be placed in <60 seconds after induction of anesthesia without the need for a muscle relaxant and use of a laryngoscope. A meta-analysis that included 3414 patients found a 17% incidence of sore throat with the LMA compared with a 39% incidence after endotracheal intubation (P < 0.00001).14 When compared with facemask ventilation, the cLMA is easy to learn and use, it secures the airway better, and decreases OR pollution from volatile anesthetics. With the cLMA, the anesthesiologist's hands are freed for other activities and not fatigued from prolonged holding of a facemask. The cLMA circumvents upper airway obstruction and the need for jaw support by bypassing the tongue and epiglottis. Compared to facemask ventilation, the cLMA may also reduce the risk of injury to the eye and facial nerve.15

Back to Top | Article Outline
Use of the LMA in Nonsupine Patients

The LMA has enjoyed success in routine practice, and enthusiasm for its use has led some to consider an expanded range of applications. The need for prone positioning classically precludes elective LMA placement for most clinicians. Nonetheless, there is experience with LMA use in prone patients. Successful airway rescue of unexpectedly extubated patients in the prone position has been reported.16 Prone airway rescue with an LMA is particularly advantageous when a patient is not easily returned to the supine position for tracheal reintubation. Elective use of an LMA in patients who are in the prone position has also garnered some attention. The LMA ProSeal (pLMA; LMA North America, San Diego, CA) was used successfully in 245 patients in the prone position based on a retrospective audit.17 The LMA Supreme (sLMA; LMA North America, San Diego, CA) has also been used successfully in prone patients, as reported in a prospective audit of 205 patients and a prospective study of 40 patients.18,19 Despite evidence to suggest the safety and utility of the elective use of the LMA for airway management of patients in the prone position, data are still insufficient to confidently recommend the technique as safe and superior to tracheal intubation in this patient population.

Back to Top | Article Outline
LMA Use for Laparoscopic and Thyroid Procedures

Laparoscopic procedures have grown greatly in popularity and breadth of application over the years. Intraabdominal insufflation with carbon dioxide is a standard technique to allow laparoscopic surgery. Traditionally, tracheal intubation has been performed for airway management during laparoscopic procedures. The cuffed tracheal tube allows positive pressure ventilation and some protection against regurgitant gastric content aspiration in the presence of a pneumoperitoneum. In contrast, EGAs were thought to be less suited for use in laparoscopic procedures. Design modifications of EGA devices have improved the ability to maintain a tight airway seal, and some devices even provide a drainage tube for the evacuation of regurgitant gastric contents. There are reports of success with the LMA for laparoscopic surgery in both pediatric and adult patients.20,21 However, definitive data proving safety and efficacy of LMA during laparoscopic surgery are lacking; large numbers are required to study the safety of this technique, especially because tracheal intubation has a long record of safety in the setting of laparoscopic procedures.

Thyroid surgery presents a special challenge for anesthetic management. Recurrent laryngeal nerve injury remains a devastating complication for patients undergoing thyroidectomy. Surgical manipulation of the airway may induce coughing, laryngeal spasm, or compression and obstruction of the airway. Despite these risks, vocal cord function has been assessed during critical portions of surgical dissection using fiberoptic bronchoscopy and a cLMA.22 Observation of vocal cord movement on stimulation of the recurrent laryngeal nerve helps the surgeon locate this vital structure. The use of an EGA that allows visualization of the vocal cords has the potential to aid in the preservation of nerve function.

Back to Top | Article Outline
Additional Nontraditional Applications of the LMA

Parturients and morbidly obese patients are not typically considered ideal candidates for elective LMA placement. Similarly, the use of an LMA for a long procedure or intensive care unit airway management may not be considered appropriate by many practitioners. Nevertheless, reports of the elective use of the LMA in parturients,23 the morbidly obese,24 and for prolonged airway management have emerged.25 Despite reports of nontraditional elective LMA use, it is important to remember that the evidence supporting such applications is scarce.

Back to Top | Article Outline
Complications of LMA Use

Aspiration of gastric contents remains the most serious potential complication of EGA use. The estimated frequency of aspiration during a cLMA anesthetic is 0.02%, but reports of aspiration during LMA use are still rare.26 This rate compares favorably to rates of 0.01% to 0.06% for anesthetized patients in general.27 The mortality rate after pulmonary aspiration has been estimated at approximately 5%.28

Gastric distension due to improper positioning of the cLMA, or excessive inspiratory pressure during controlled ventilation, may encourage regurgitation and negatively impact pulmonary mechanics, especially in children.29 A malpositioned cLMA can partially or completely obstruct an airway when the aryepiglottic fold is displaced anteriorly toward the larynx. Mechanical kinking or twisting of the cLMA's ventilating shaft can occur because of torque from the ventilating circuit, impairing ventilation. The possibility of regurgitation and aspiration with the cLMA in high-risk patients, however, should not prevent the emergency use of the device if attempts at tracheal intubation and facemask ventilation have failed.

The inflated mask cuff of the cLMA exerts pressure on surrounding tissue to allow a seal for ventilation, but excessive cuff pressure can result in complications. The pressure transmitted to the pharyngeal mucosa by the cuff of the cLMA can exceed tissue capillary perfusion pressure.30 Manufacturer recommendations advise a maximum cuff pressure of 60 cm H2O (44 mm Hg) for LMA products, and also suggest maximum volumes for air inflation of the cuff. Unfortunately, intracuff pressure is not solely a function of the device design. Cuff pressure can vary from patient to patient, and excessive cuff pressure is possible with minimal cuff inflation, particularly in pediatric patients.31 The degree of tissue trauma from cuff compression is unknown. Compression paralysis of the 12th cranial nerve,32 hypoglossal nerve,33 and bilateral recurrent laryngeal nerve34 has been reported. Diffusion of nitrous oxide into the cLMA cuff has produced intracuff pressures as high as 110 mm Hg.8 The variability of intracuff pressures for a given volume of air among individual patients supports a need for routine monitoring of intracuff pressure during the use of cuffed EGAs. Although pressure monitoring is not universally accepted as necessary, the use of a simple manometer can confirm that cuff pressures are not excessive.

Back to Top | Article Outline
LMA Flexible

The LMA Flexible (fLMA; LMA North America, San Diego, CA) is designed to be useful for intraoral procedures in which a semirigid ventilation shaft would either obstruct the procedure or kink when displaced for surgical exposure. It consists of a flexible ventilating shaft attached to a cuffed mask similar to the cLMA (Fig. 3). The wire-reinforced ventilating shaft of the fLMA offers flexibility but can compromise ventilation if the tube is crimped or damaged from previous use. The ventilating shaft should be inspected for signs of damage from prior use before the device is reused. It has been suggested that the fLMA is more difficult to insert than the cLMA unless a stylet or introducer tool is used.35 The recommended insertion technique is the same as that for the cLMA. The junction of the mask and the ventilation shaft, a focal area for an index finger insertion technique, is not fundamentally different between the cLMA and fLMA. Despite the theoretical challenge of managing a flexible ventilating shaft during insertion, evidence suggests that insertion success is not different between the cLMA and fLMA.36

Figure 3
Figure 3
Image Tools
Back to Top | Article Outline
LMA ProSeal

The pLMA (LMA North America, San Diego, CA) was introduced in 2000 as the first EGA with two tubes for end-to-end contact with the respiratory and alimentary tracts37 (Fig. 4). A drain tube in the pLMA separates the esophagus from the larynx. If the drainage tube is positioned correctly, it reduces the risk of aspiration if regurgitation occurs.38 A second cuff, behind the main body of the mask, increases contact with the posterior pharyngeal wall, increasing oropharyngeal leak pressure to an average of 25 cm H2O.39 Pediatric sizes have a drainage tube but no posterior cuff. A higher oropharygeal leak pressure is useful for laparoscopic surgery, in patients with reduced lung compliance, or in obese patients who may need higher ventilation pressures.40 As with other EGAs, the pLMA is contraindicated in nonfasting patients, for whom tracheal intubation remains the technique of choice.

Figure 4
Figure 4
Image Tools

There are several pLMA insertion techniques: the index finger technique as recommended with the cLMA; with the help of an introducer tool; or by advancement into the hypopharynx over a gum elastic bougie or gastric tube placed into the esophagus via the drainage tube.41,42 Unlike the cLMA, the pLMA requires strict adherence to the recommended insertion techniques. A multicenter study comparing the pLMA and cLMA in anesthetized patients revealed first attempt insertion success at 92% for the cLMA versus 82% for the pLMA.39 After 3 attempts, success rates were similar (cLMA 100% vs pLMA 98%). Time to establish an airway was quicker with the cLMA (31 seconds) than with the pLMA (41 seconds), though these differences are likely clinically irrelevant. Seal pressure was better with the pLMA (27 vs 22 cm H2O). Total intraoperative complications and the incidence of postoperative sore throat were similar.

In addition to decompression of the stomach and removal of regurgitant contents, the pLMA drain tube can be used to confirm the proper position of the device. The drainage lumen can be used to confirm proper position using the suprasternal notch test, an air leak test, or orogastric tube placement.37,43,44 In the suprasternal notch test, a water-soluble lubricant or nontoxic soap solution is used to form a meniscus over the end of the gastric drainage tube next to the ventilating lumen. The tracheal rings in the suprasternal notch are gently compressed while the meniscus on the drainage lumen is observed for motion of the lubricant or bubble formation. In a properly positioned pLMA with a patent drainage lumen, the meniscus moves because pressure is transmitted from the proximal esophagus during compression of the suprasternal notch. During the leak test, positive pressure is applied to the ventilating lumen while observing the lubricant meniscus on the drainage lumen for displacement or bubble formation. It is normal to see slight movement of the meniscus with respiration because the drainage port pressure reflects esophageal pressure, which varies during inspiration and exhalation. The leak test verifies separation between ventilating and drainage lumens. Having a negative leak test, i.e., minimal or no movement of lubricant or soap meniscus with positive airway pressure, is a necessary but not sufficient condition to indicate proper pLMA position. It is possible for the cuff of the pLMA to fold backwards on itself during insertion, yielding a patent airway with an occluded drainage lumen.45 The easy passage of a gastric tube through the drainage lumen should be ascertained to confirm proper pLMA position. Smooth passage of a gastric tube into the stomach confirms that the pLMA is not folded and that the lumen is patent and aligned with the esophagus.

Back to Top | Article Outline
Intubating LMA (LMA Fastrach)

The LMA Fastrach (iLMA, LMA North America, San Diego, CA) was released in 1995. This intubating LMA has a curved metal shaft designed to fit into the oropharyngeal space while the patient's head and neck are in neutral position (Fig. 5). The iLMA replaces the aperture bars of the cLMA with a single epiglottic elevating flap attached only at its anterior end. During intubation, the tip of the flap is pushed up by the tracheal tube, deflecting the epiglottis anteriorly for passage of the tracheal tube through the glottis. Because of the rigid handle, one-handed insertion is possible from any position without extension of the patient's head, a useful feature for patients with limited cervical spine mobility. The shaft is shorter than that of the cLMA, which increases the length of tracheal tube that can be advanced beyond the mask orifice.

Figure 5
Figure 5
Image Tools

In a multicenter study involving placement of the iLMA in 500 patients, ventilation was satisfactory in 95%; it was difficult in 4% and impossible in 1%.46 Blind tracheal intubation through the iLMA was successful in 96.2% of patients after 3 attempts. The efficacy of the iLMA was also demonstrated in patients with abnormal airways47 and in obese patients.48 Ferson et al. examined 254 patients with known or suspected difficult airways. Insertion of the iLMA and successful ventilation were accomplished in all patients within 3 or fewer attempts.47 Similar to prior reports, the success rate for blind intubation was 96.5%. The tracheas of all patients with failed blind intubation via the iLMA were successfully intubated with the aid of a flexible bronchoscope introduced via the iLMA.47 The combination of the iLMA and fiberscope-assisted tracheal intubation via the device is a powerful technique to manage challenging airways. With the iLMA, a stable airway can be established rapidly, particularly in patients with anatomic features that complicate mask ventilation. Thus, the fiberscope operator bypasses most of the soft tissue in the oropharynx so that the fiberscope emerges from the mask near the glottic opening. Ventilation can also continue during the intubation process if the tracheal tube is inserted into the iLMA and a bronchoscope swivel adapter is placed between the anesthesia circuit and the 15 mm adapter on the tracheal tube.

Successful intubation with the iLMA depends on 4 factors: mask size selection, position of the patient, adjunctive maneuvers, and the type and orientation of the tracheal tube. A number of criteria for size selection have been suggested. The manufacturer's instructions suggest weight-based sizing, which does not consider variations in airway anatomy among patients of similar size. Sex, height, and nose-to-chin distance have been suggested as a basis for iLMA selection, although some argue that sizes 4 and 5 work better than size 3 for ventilation in men and women.49 An approximate size can be estimated by holding the iLMA next to the patient's head to determine the eventual position of the iLMA mask relative to the mouth. The iLMA is positioned next to the patient's head so that the cranial surface of the shaft is positioned at the level of the upper incisors or the hard palate for edentulous patients. If the iLMA is properly sized, the middle of the epiglottic elevating flap is at the level of the thyroid notch. This sizing guideline helps ensure that the tracheal tube will deploy directly into the larynx. If the LMA is too big, the tracheal tube may enter the esophagus. If it is too small, it may get caught into the vallecula.

The iLMA is inserted with the patient's head and neck in a neutral position. If ventilation or tracheal tube insertion is inadequate or unsuccessful, the “up-down” and “Chandy” maneuvers can be applied.47,50 For the up-down maneuver, the iLMA is pulled out approximately 6 cm with the cuff inflated and then reinserted into the hypopharynx. This maneuver usually corrects the downfolding of the epiglottis, which is often responsible for airway obstruction and difficulty with iLMA-assisted endotracheal intubation. The Chandy maneuver has 2 parts. The first is gentle manipulation of the iLMA handle in the horizontal and sagittal planes to adjust positioning during hand ventilation. The astute operator can discern when airway resistance is at a minimum. Usually the position that provides lowest resistance and best ventilation is also the position that is best for intubation. The second part of the Chandy maneuver involves lifting the iLMA handle anteriorly to displace the device away from the posterior pharyngeal wall. Both components of the Chandy maneuver attempt to align the iLMA mask orifice to optimize tracheal intubation.

The type of tracheal tube and its orientation within the iLMA also influence the success of intubation. A wire-reinforced silicone tracheal tube designed for the iLMA has a soft, specially shaped tip, has no natural curve or camber, and is more flexible than a standard PVC tube. Despite success with blind iLMA-assisted tracheal intubation using the iLMA silicone tube, success has also been shown with various PVC tracheal tubes.51 In addition to the material of the tracheal tube, the orientation of the tube during insertion via the iLMA is also a consideration. Camber refers to the curved shape of PVC tracheal tubes. During intubation via direct laryngoscopy, the tracheal tube is inserted with forward camber, which directs the concavity of the tube anteriorly. If a PVC tube is inserted through an iLMA with forward camber, the tip of the tube as it emerges from the intubation shaft is not well-aligned with the axis of the trachea. Tracheal intubation with the tube inserted with reverse camber was first reported by Joo and Rose.52 Reverse-camber insertion, i.e., the concavity facing posteriorly, improves the angle of emergence of a PVC tube through the iLMA, resulting in a higher first attempt intubation success rate.53 Overall success rates, beyond first attempt, showed no difference with normal and reverse camber orientation.53 A 96% success rate for intubation within 2 attempts was reported with PVC tubes in normal orientation and with silicone wire-reinforced tubes.54

Back to Top | Article Outline
LMA Supreme

In 2007, the disposable LMA Supreme (sLMA) became available as an alternative to the reusable pLMA. The sLMA combines some features of 3 previously introduced LMAs: the uLMA (disposable), the iLMA (rigid curved shaft), and the pLMA (gastric access) (Fig. 6). The sLMA is designed for ease of insertion, it has a gastric drainage tube and provides a high seal pressure. The mask has a narrower transverse diameter than previous LMA models, allowing it to be placed in patients with a smaller mouth opening. The internal webbing of the tip keeps the drain tube open, and the fins within the bowl of the sLMA protect the airway from epiglottic obstruction. Two preliminary studies demonstrated a placement success rate of 96% to 98%.a55

Figure 6
Figure 6
Image Tools
Back to Top | Article Outline
LMA Classic Excel

The LMA Classic Excel (eLMA, LMA North America, San Diego, CA) is designed to aid tracheal intubation. It is similar to the cLMA in appearance, except for an epiglottic elevating bar that replaces the aperture bars in the cLMA (Fig. 7). The 15-mm adapter of the eLMA can be removed from the ventilating lumen. Experience is limited with this device, due to its recent introduction. The eLMA provides an alternative to the intubating LMA for cases requiring an EGA to aid tracheal intubation.

Figure 7
Figure 7
Image Tools
Back to Top | Article Outline
Other EGAs

After the successful introduction of the cLMA, several other EGAs were introduced. Despite the widespread commercial availability of alternative devices, none has been studied as extensively as the LMA.

Back to Top | Article Outline
Ambu Laryngeal Masks

The Danish medical device manufacturer Ambu A/S (Ambu, Glen Burnie, MD) launched their version of a laryngeal mask, the AuraOnce, in 2004.67 The Ambu AuraOnce has an elliptical, inflatable cuffed mask attached to an airway shaft with a standard connector. It is similar to the cLMA but without aperture bars in the bowl of the mask. The shaft is curved at an almost 90° angle for easy insertion. The AuraOnce cuff, mask, and tube are molded together as a single unit that is latex-free. Indications, contraindications, and disadvantages of the AuraOnce are similar to those of the cLMA. In a multicenter trial involving 118 adult patients, the first-attempt success rate for intubation was 92.4%, ventilation was adequate in all patients, and the vocal cords could be seen with a fiberoptic bronchoscope in 91.5% of patients.68 In another study, the AuraOnce functioned satisfactorily when tested in patients in 5 different head positions.b This feature may be beneficial for patients who undergo head or neck surgery. In 80 patients who had minor gynecologic procedures, the AuraOnce and the uLMA performed equally, with the exception of a slightly higher airway leak pressure with the AuraOnce.57 Other versions include the AuraFlex (Fig. 8) (Ambu, Glen Burnie, MD), which has a flexible airway shaft; the AuraStraight (Fig. 9) (Ambu, Glen Burnie, MD), which has a straight shaft; and the reusable version of the AuraOnce, the Aura40 (Ambu, Glen Burnie, MD). A newer model, the Aura-i (Fig. 10) (Ambu, Glen Burnie, MD), is designed to facilitate 1-step tracheal intubation with fiberoptic guidance via the device in pediatric and adult patients. Blind intubation via the Aura-i is not recommended.

Figure 8
Figure 8
Image Tools
Figure 9
Figure 9
Image Tools
Figure 10
Figure 10
Image Tools
Back to Top | Article Outline
Air-Q/Intubating Laryngeal Airway

Developed by Dr. Daniel Cook and introduced in 2004, the air-Q/Intubating Laryngeal Airway (air-Q/ILA, Cookgas LLC, St. Louis, MO, USA) is an EGA for use as a primary airway device or as an adjunct to tracheal intubation. The air-Q/ILA is available as a disposable (air-Q) or nondisposable (ILA) device (Fig. 11). It has an elliptical, inflatable, cuffed mask and a slightly curved airway tube with a detachable connector.

Figure 11
Figure 11
Image Tools

The air-Q/ILA has several unique features designed to assist tracheal intubation. In most other EGAs, the length of the shaft, fixed 15-mm adapter, and mask aperture bars complicate blind tracheal intubation. The air-Q/ILA has a shorter shaft than the cLMA, no aperture bars within the mask, a removable connector so that the wide lumen of the shaft can be used for intubation, and a keyhole-shaped distal airway tube to direct a tracheal tube toward the larynx. If ventilation with the device is unsatisfactory, the “Klein maneuver” corrects downfolding of the epiglottis by using a jaw thrust and an up-down maneuver of the ILA.c The ILA is not recommended for patients at risk for aspiration, those with poor lung compliance, or with lesions of the oropharynx or epiglottis.

During tracheal intubation through the air-Q/ILA, the tracheal tube is advanced to a depth of 12 to 15 cm so that the tip of the tube is close to the air-Q/ILA opening. The tube is then advanced into the trachea blindly or with the aid of a fiberoptic bronchoscope. Once tracheal intubation is successful, the ILA can be left in place as a bridge to extubation at the conclusion of the anesthetic. Alternatively, removal of the ILA immediately after tracheal intubation can be assisted by a stylet produced by the manufacturer. Blind intubation success via the air-Q/ILA improves with use of a flexible reinforced tracheal tube.

Back to Top | Article Outline
Cobra Perilaryngeal Airway (Cobra PLA)

The Cobra Perilaryngeal Airway (Cobra PLA; Pulmodyne, Indianapolis, IN) was introduced by Dr. David Alfrey in 1997. It has a large diameter airway tube with a high-volume, low-pressure pharyngeal cuff located proximal to the wide distal Cobra head (Fig. 12). The wide head keeps soft tissues away from the glottis to maintain a patent airway. When inflated, the cuff displaces the base of the tongue to expose the glottis. The Cobra PLA, which does not have a gastric channel, can be used as an adjunct to tracheal intubation. The Cobra head has a soft, flexible grill for passage of a tracheal tube. The Cobra PLUS models allow monitoring of body temperature using an integrated thermistor, and distal CO2 gas sampling in its pediatric sizes. For successful placement, the patient's head is placed in the sniffing position, the device is lubricated, the mouth is opened with a scissor motion using the nondominant hand, and the Cobra PLA is advanced straight back between the tongue and hard palate. Modest neck extension and anterior jaw lift aid placement. Properly placed, the tip of the Cobra lies posteriorly to the cricoid cartilage, the ramp grill lifts the epiglottis, and the cuff lies in the hypopharynx at the base of the tongue.

Figure 12
Figure 12
Image Tools

Comparison of the Cobra PLA to the uLMA showed similar ease of insertion and success in obtaining a patent airway.58 Gaitini et al. studied 80 patients, divided evenly between the Cobra PLA and uLMA; airway adequacy, number of adjustments made, and minor complications were the same with both devices, but the cuff pressure required to prevent a leak of the Cobra PLA was more than that of the uLMA.

Comparison of the Cobra PLA to the cLMA found similar results for both spontaneous and positive-pressure ventilation, but oropharyngeal leak pressure was higher with the Cobra airway, 23 ± 6 cm H2O versus 18 ± 5 cm H2O for the cLMA.59 In a series of 110 patients, Cobra placement was 100% successful with no major complications, and required a mean cuff leak pressure of 34 cm H2O.60

Back to Top | Article Outline
Esophageal Tracheal Combitube

The design of the Esophageal-Tracheal Combitube (Covidien-Nellcor, Boulder, CO) is a major advance based on earlier esophageal obturator devices (Fig. 13). As an alternative device to secure the airway, it has proven especially useful for prehospital use or when the operator lacks the skills for facemask ventilation or tracheal intubation.61 The device is designed to be inserted blindly and ventilation can be established whether it enters the esophagus or the trachea.62 The Combitube requires less training to master, does not require as much continuing use to maintain proficiency as direct laryngoscopy, and is easier to insert than a traditional tracheal tube. It is a disposable double-lumen, double-cuffed device with separate pilot balloons for the proximal and distal cuffs. The distal lumen (known as lumen #2) is clear and terminates at the end of the device. Lumen #1 is colored blue and terminates in several small fenestrations located between the proximal and distal cuffs (Fig. 13). The Combitube is available in 37-Fr and 41-Fr sizes; the 41 Fr is for adults taller than 6 feet.63 When inserted blindly, it typically enters the esophagus stabilizing the device and providing access to the stomach for decompression. The proximal tube #1 provides ventilation of the patient's lungs when the Combitube is placed in the esophagus. Once placed, confirmation of position can be obtained by auscultation for lung sounds during ventilation via tube #1. The absence of lung sounds, or the presence of gastric insufflation during ventilation via lumen #1 indicates esophageal ventilation, and ventilation should be switched to lumen #2.62 Less than 5% of the time, the Combitube enters the trachea; in this position, lumen #2 is used as a tracheal tube for ventilation. If ventilation is not possible via either lumen, it may be due to the Combitube being inserted too deeply. Despite the utility of auscultation for placement confirmation, the additional use of capnometry (i.e., Easycap, Nellcor, Inc., Pleasanton, CA) or an esophageal detector (i.e., TubeChek, Ambu, Linthicum, MD) is advisable to ensure proper use.62,63 The Combitube may be placed blindly or under direct vision with the help of a rigid laryngoscope. It can be placed in patients with a mouth opening as small as 15 mm and is helpful in “cannot-intubate-cannot-ventilate” situations, especially when other EGAs have failed. The Combitube does not require movement of the patient's head or neck, an advantage for patients with cervical spine pathology. Unconsciousness with absence of a gag reflex or a combination of light anesthesia and a muscle relaxant are needed for placement.61

Figure 13
Figure 13
Image Tools

There are several advantages of the Combitube: it requires minimal preparation; blind insertion is possible; it can be positioned in the trachea or esophagus; it reduces aspiration risk; it is less invasive than a cricothyrotomy; neck extension of the patient is unnecessary during insertion; stomach decompression is possible; and positive pressure ventilation is possible.62 Disadvantages of the Combitube airway include an inability to suction the trachea when placed in the esophageal position, except with a redesigned version that has a large opening for suctioning and for airway evaluation through a fiberoptic bronchoscope.64 Because of the tendency of the Combitube to intubate the esophagus when inserted, its use is contraindicated in those who have ingested caustic substances, or in patients with known upper esophageal pathology such as Zencker's diverticulum or esophageal varices. Complications associated with the use of the Combitube include laceration of the esophagus, esophageal rupture, tongue engorgement and venous congestion, and inability to ventilate.65

Back to Top | Article Outline
EasyTube

Similar to the Combitube, the Rusch EasyTube (Teleflex Medical, Research Triangle Park, NC) has the same general shape, applications, and insertion technique. It was introduced in 2003 by Frass and colleagues. The latex-free device is available in 2 sizes for use in adults (130 cm or taller) or children (90 to 130 cm tall). The pharyngeal lumen between the 2 balloons of the EasyTube opens into the pharynx via a single open end for passage into the trachea of a fiberoptic bronchoscope, suction catheter, or tube changer. The distal tube is similar to a tracheal tube and has a Murphy eye.

Back to Top | Article Outline
Laryngeal Tube

The Laryngeal Tube (LT; King Systems, Noblesville, IN) was introduced in Europe in 1999 and in the United States in 2003. There are several different LT airways in the LT family, and all these devices are shorter than many other EGAs. The silicone tubes are curved slightly and have two cuffs, a small distal esophageal and a larger proximal pharyngeal cuff (Fig. 14). A single inflation line serves both low-pressure, high-volume cuffs. After inflation, the distal cuff seals the esophagus and the proximal cuff seals the hypopharynx, allowing for ventilation through the larynx via the ventilating lumen between the cuffs. The LT can serve as an adjunct to tracheal intubation because its primary ventilating passage accepts a flexible bronchoscope or tube exchanger. The ventilating lumen is located between the proximal and distal cuffs. The LT is reusable and has a blind tip. Additional models include the disposable Laryngeal Tube (LT-D), and the disposable Laryngeal Tube Suction (LTS-D), which has a suction channel leading to an opening at its distal tip. In 2004 the Laryngeal Tube Suction II (LTS II; VBM, Medizintechnik, Sulz am Neckar, Germany, not available in the United States) was introduced; it has a longer shaft than the LTS, as well as a modified tip and cuff shape. The LTS II is available in pediatric sizes and most resembles the King LTS-D.66

Figure 14
Figure 14
Image Tools

Before insertion of the LT, both cuffs are deflated and lubricated. The head of the patient is placed in neutral or sniffing position with jaw lift. The LT is placed in the mouth along the midline of the tongue with the tip against the hard palate and directed in a caudal direction until resistance is felt. The cuffs are inflated up to 60 cm H2O pressure. Auscultation of breath sounds during ventilation via the ventilating lumen serves to confirm proper position, although the addition of capnometry is advisable as is standard with tracheal intubation. LT models with esophageal ports LTS-D, LTSII, and G-LT (see below) are not designed to allow ventilation should the distal tip of the device enter the trachea. The soft tip and low-pressure cuff are designed to minimize tissue trauma, sore throat, hoarseness, and airway bleeding.

The LT is a reliable device for airway management during elective surgery.67 First attempt insertion success has ranged between 86% to 94%.67,68 Tracheal intubation via the LT was successful in 3 patients after the cLMA proved unsatisfactory because the pharyngeal space was narrowed by enlarged tonsils.69 Leak pressure performance for the LT and LTS-D appears to be similar to that of the pLMA.70,71 The newer LTS II was found to be more difficult to insert and have a lower leak pressure than the pLMA.66

A new version of the LT, the Gastro-Laryngeal Tube (G-LT, VBM Medizintechnik, GmbH, Sulz am Neckar, Germany) is now available. The G-LT is designed for use in gastrointestinal endoscopy cases. It provides a conduit to the esophagus that accommodates a gastroscope. The esophageal lumen is wide and has a distal cuff that can be inflated to seal the esophageal inlet. Ventilation is established via a separate lumen that terminates distally to the larger pharyngeal cuff. The G-LT has the theoretical advantage of controlled airway management without endotracheal intubation while providing easy access to the upper gastrointestinal tract for endoscopic procedures.

Back to Top | Article Outline
I-GEL

The i-gel (Intersurgical, Wokingham, Berkshire, UK), invented by Dr. Muhammed Nasir, is anatomically designed to conform to the hypopharynx without using an inflatable cuff. The mask surface is made of a gel-like thermoplastic elastomer, which is soft and conforms to the larynx (Fig. 15). The mask bowl lacks aperture bars, providing free passage of an endotracheal tube. The shaft has an integral bite block and is flattened to resist rotation. A second lumen runs along the entire length of the device to the distal tip to accommodate a nasogastric tube for drainage of potential regurgitant gastric contents. The i-gel is intended for single use and is available in 7 sizes, pediatric to adult.

Figure 15
Figure 15
Image Tools

A comparison of the i-gel, cLMA, and pLMA found that the seal pressures of the i-gel and the pLMA were comparable, and higher than the cLMA seal pressure. Success rates of initial insertion were similar among the devices.72 Early published experience with the i-gel suggests ease of use, a high success rate for first attempt insertion, and good fiberoptic visualization of airway structures through the device.

Back to Top | Article Outline
Streamlined Liner of the Pharynx Airway

The Streamlined Liner of the Pharynx Airway (SLIPA; SLIPA Medical, Douglas, Isle of Man) resembles a slipper that lines the pharynx. It was developed by Dr. Donald Miller and introduced in Europe in 2004 (Fig. 16). This disposable, cuffless device has an enlarged cavity for trapping regurgitated fluids. The soft plastic mask includes a gastric port that leads to the hollow cavity within. The airway shaft of the SLIPA is flexible at its attachment to the mask and rigid more proximally to its 15 mm adapter. The SLIPA device is rigid at room temperature but softens once inserted. For placement, the patient's head is extended, and the SLIPA is angled toward the esophagus until the heel of the device reaches the pharynx.73 The SLIPA is available in 6 adult sizes selected according to patient height. When compared to the cLMA, insertion success rates, airway seal pressures, and incidence of sore throat were similar.7375

Figure 16
Figure 16
Image Tools
Back to Top | Article Outline
Use of EGAs for Special Situations
Prehospital

The prehospital setting poses numerous challenges to successful airway management. Advanced airway expertise is often lacking, the physical conditions under which care must be provided are suboptimal, and planned preparation is often impossible. Tracheal intubation is considered the “gold standard” for definitively securing an airway, but the skills necessary to accomplish this task are often not available in the prehospital setting. In addition, patients are often not fasted and are at risk for regurgitation of gastric contents and subsequent pulmonary aspiration. Trauma or environmental hazards may make visualization of airway structures during direct laryngoscopy difficult or impossible. EGAs have many advantages in the prehospital setting. They are designed for blind insertion, do not require laryngoscopy, and may establish a reliable ventilating airway better than bag mask ventilation. The first use of the cLMA for emergency prehospital airway control was reported by Greene et al. in 1992.76 Because the cLMA is relatively easy to insert, it was soon promoted as an emergency airway device. Nurses, paramedics, and other inexperienced personnel have been highly successful in first attempts at cLMA placement.77,78

The Combitube has been popular for use in trauma and nontrauma patients. In one study, a Combitube was a helpful adjunct for airway management after failed tracheal intubation following rapid sequence induction of 12 patients with facial trauma and fractured mandible.79

The LT has also been used successfully in the prehospital setting. In one study of 157 patients who required prehospital airway management, the success rate for LT insertion and ventilation was 96.8%.80 Patients were managed outside of the hospital by paramedics in 70 of the 157 cases, the rest were cared for by emergency physicians in the same setting.

Back to Top | Article Outline
Resuscitation

Airway management is a critical component of cardiopulmonary resuscitation. One of the goals of treating patients in respiratory arrest is to maintain a patent airway for oxygenation and ventilation. It is often difficult for the nonexpert to establish adequate ventilation with the commonly used facemask and self-inflating bag. EGAs have been used successfully to overcome this problem by providing a stable ventilating airway that does not require the advanced skill of a practitioner to maintain an adequate seal. In one study, 130 nurses trained in the use of the LMA placed the device within 3 attempts during resuscitation of 164 patients who suffered cardiac arrest.78 The success rate on the first attempt was 71%; for the second attempt, 26%. The overall failure rate was only 12%. Tracheal intubation proved difficult in 11 of these patients when attempts were made to replace the LMA with a tracheal tube. The LMA was properly replaced, and satisfactory ventilation continued in all patients in whom tracheal intubation had failed previously. Thirty-three patients (20%) showed evidence of regurgitation. However, it is important to note that 20 of the 33 patients who regurgitated did so before LMA placement, 3 regurgitated during LMA insertion, and in the remaining 10, regurgitation occurred after LMA removal. Only 1 patient (0.6%) had clinical evidence of pulmonary aspiration. In fact, it appears that the incidence of regurgitation of gastric contents during resuscitation using an LMA is similar to, if not less than, that during self-inflating bag mask ventilation.81

Several studies have compared the use of the Combitube for resuscitation after cardiac arrest outside or inside the hospital.82,83 In the hospital, the Combitube was as effective as a tracheal tube. When compared to physicians performing tracheal intubation, nurses were able to place a Combitube with a similar success rate, but in a shorter period of time.

Back to Top | Article Outline
Obstetrics

The cLMA can be lifesaving in cesarean deliveries when tracheal intubation and mask ventilation have failed. LMAs with a drain tube (such as the ProSeal and the Supreme) theoretically offer better protection against regurgitated stomach contents than the cLMA, but protection is not as reliable as with a cuffed tracheal tube. Repeated attempts at tracheal intubation using different techniques may be more dangerous than placing a pLMA to secure the airway and passing a gastric tube to decompress the stomach. Because of the nature of the surgery and the limited time involved, cesarean delivery can be completed with an EGA in place. Although a rapid sequence induction with tracheal intubation remains common for obstetric general anesthesia, elective use of an EGA for patients undergoing a cesarean delivery has been described.23 In a large cohort study, 1067 parturients with a preference for general over regional anesthesia were scheduled for elective cesarean delivery with an LMA. Patients with a perceived or known difficult airway, a pregravid body mass index >30, ASA physical status >2, and with pharyngeal reflux, were excluded. An effective airway using an LMA was established in 99% of patients, 0.7% of patients required intubation, and there was no evidence of regurgitation or pulmonary aspiration in this selected patient group.

Back to Top | Article Outline
Pediatrics

Pediatric patients present special challenges for the design and use of EGAs. The transition from pediatric to adult airway does not occur at a predictable age. Pediatric versions of the cLMA are smaller scale versions of the adult model. Yet, pediatric anatomy is not simply miniaturized adult anatomy. Young children typically have a more cephalad glottis, and a more funnel-shaped than cylindrical airway in comparison with that of an adult.84 As children approach their teen and even preteen years, their airway may become anatomically adult. Not all EGAs can be downsized for pediatric use to maintain good function, and availability of devices suitable for the smallest patients is limited (Table 3). Studies suggest a high incidence of epiglottic downfolding with smaller LMA sizes, as confirmed by a fiberscope assessment through the LMA.85,86 Despite potential downfolding of the epiglottis, clinically significant airway obstruction was not present in the majority of patients studied. The first pediatric sizes of the cLMA were size 1 (for children weighing <6.5 kg) and size 2 (for children weighing 6.5 kg to 25 kg). Two additional sizes, 1.5 and 2.5, have since been added.

Table 3
Table 3
Image Tools

Pediatric sizing and anatomy are important considerations, but pediatric physiology must also be considered. Children have a limited tolerance for apnea and a tendency toward laryngospasm. Unintended gastric insufflation during positive pressure ventilation is common in pediatric patients.29 Gastric distension not only makes ventilation more difficult, but may also predispose to regurgitation of gastric contents. Unintended dislodgment of the EGA is possible with relatively minor manipulation of the patient or device, particularly in infants. However, despite differences in airway anatomy and physiology, the overall experience with pediatric cLMAs has been favorable, with some notable exceptions, such as increased epiglottic downfolding that may complicate blind intubation techniques.85,87

Indications for EGA use in children generally mirror those for adults. Extraglottic devices can be used as a primary airway, a rescue airway, an adjunct device during difficult intubation, or for special situations in or outside the OR (Table 4). When an unexpected need for pediatric airway management arises, personnel with airway expertise may not be available. In situations where tracheal intubation is not feasible, ventilation may be established with a pediatric EGA.88 Besides emergent resuscitation, an EGA can be used to ventilate a child's lungs during transport to a location that can provide pediatric personnel and resources.89

Table 4
Table 4
Image Tools

Contraindications to use of an EGA in children are similar to those for adults. Among them is the risk of gastric regurgitation and the potential for pulmonary aspiration. There are design modifications meant to lessen the chance of pulmonary aspiration but not to the degree provided by cuffed tracheal intubation. A full stomach, active gastric reflux, intrapharyngeal masses or pathology, and the need for high inspiratory ventilatory pressures because of lung pathology or procedure type are typical contraindications for the use of a pediatric EGA.

Compared to adults, the risk of pressure injury to the airway in children may be greater with the use of EGAs. Of particular concern for pediatric practitioners is the potential for higher cuff pressures from small devices placed in small airways. High pressures may increase the risk of injury to the surrounding mucosa and structures of the pharynx. A review of 400 pediatric patients managed with either the cLMA or the uLMA found median cuff pressures of 90 cm H2O to >120 cm H2O, pressures that were much higher than the manufacturer's recommended maximum of 60 cm H2O.90 The effect of high cuff pressures on vital structures is not easy to predict, but mucosal lesions from hypoperfusion, nerve injury, and sore throat seem likely risks.3234 In an observational study of 400 children, the likelihood of postoperative sore throat increased with higher cuff pressures. Among the children who had either the cLMA or uLMA (n = 139), 17% had a sore throat; in 56% of sore throat cases, cuff pressures were >100 cm H2O.91 When cuff pressures were <40 cm H2O, children did not experience sore throat.

Excessive cuff pressure is not always a result of overzealous cuff inflation. A review of 1000 children managed with different sizes and brands of LMAs revealed some interesting results.31 Only the volume of air already present in the device as packaged was used during placement. In 20.5% of cases, cuff pressures were ≥60 cm H2O. Of the smaller size 1 devices, 66.6% had cuff pressures ≥60 cm H2O when just the packaged volume of air was present in the cuff. These results suggest that smaller-sized devices may need to be deflated after placement to achieve pressures <60 cm H2O. Mounting evidence warns against reliance on subjective clinical indicators of appropriate cuff volumes and pressures in pediatric patients. With devices such as a simple manometer, cuff pressures can be monitored to avoid potential morbidity.92 Pediatric versions of the fLMA, pLMA, sLMA, and uLMA are on the market (Table 2). Similar to its adult counterpart, the pediatric pLMA is designed with a cuffed mask bowl and a gastric drainage port but does not have the posterior cuff found on the adult sizes. Multiple studies have compared the cLMA to the pLMA in pediatric patients.93,94 Evidence suggests that the pediatric pLMA has a high success rate for first pass insertion, and typically provides a higher leak pressure relative to the equivalent pediatric cLMA.95

The pediatric fLMA is useful when the ventilating shaft of a typical EGA device interferes with a procedure. Children receiving radiation therapy to the head may require a special mask that can limit access to the airway, thus complicating airway management. The fLMA often works well for these patients as it does in many patients having tonsillectomies, dental procedures, and other procedures surrounding the mouth. Unlike adults, in whom there may be other options, general anesthesia is frequently required in children who undergo daily radiotherapy, dental procedures, or head or neck operations, creating a niche for the fLMA in pediatric practice.96,97

There is a paucity of literature evaluating newer EGA devices in children.98 Most of the available evidence consists of case reports or small trials. Pediatric models of the Cobra PLA have been used successfully in children, but epiglottic downfolding that obstructs the view of the vocal cords was noted by fiberoptic bronchoscopy in children weighing <10 kg.99 Other studies of children weighing >10 kg found little obstruction of vocal cord view with fiberoptic bronchoscopy via the Cobra PLA.100,101 When Passariello et al. evaluated Cobra PLA sizes 1.5 and 2 in. 40 children, they found that gastric insufflation increased in 21% of patients, even with ventilation pressures ≤20 cm H2O.102 Conversely, Szmuk et al. found less gastric insufflation with the Cobra PLA when the Cobra PLA was compared with the uLMA in 200 children.101

The i-gel is also available in pediatric sizes. An observational study of 50 children found the device easy to insert and an effective airway in patients who weighed 30 kg or more.103 Evidence of efficacy and safety in children, particularly smaller children, is lacking at this time.

Pediatric sizes of the LT family are limited (Table 2). Versions of the LT, LT-D, and LTS II that are suitable for patients as young as neonates are available. An observational study of the use of the LTS II in 10 children with anticipated or unexpected difficult airway aged 6 months or younger found a high ease of use and insertion success.104 A comparison of the cLMA and the LT in a randomized group of 60 children aged 2 to 8 years found a high insertion success rate for both, with a higher airway leak pressure for the LT.105

A retrospective review of air-Q use for the management of 34 children (age 16 years or younger) with difficult pediatric airways found it useful as a conduit for tracheal intubation.106 A recent prospective evaluation of the air-Q as a conduit for tracheal intubation of children with normal airways found it to be an effective tool when combined with fiberoptic bronchoscope guidance.107 The air-Q accommodates a larger tracheal tube than the equivalent size cLMA or uLMA. The air-Q is particularly attractive in pediatric practice because there are no pediatric sizes of the ILMA. Pediatric sizes of the Ambu Aura-i are another choice for pediatric EGA-assisted endotracheal intubation in children. Pediatric versions of the LMA Excel are in development.

Back to Top | Article Outline
EGAs and the Difficult Airway

Before the introduction of the LMA, difficult airway management focused on methods to optimize facemask ventilation and tracheal intubation. Clinicians had limited tools to facilitate ventilation and much effort was placed on tracheal intubation. Mortality and morbidity in airway management are more likely the result of failure to establish ventilation than failure to intubate the trachea. Many factors associated with failed rigid laryngoscopic intubation do not affect the insertion of an EGA. Depending on the situation and the user's level of expertise, the EGA can be introduced at various points described in the ASA algorithm for the difficult airway.3 When the LMA was introduced in clinical practice, clinicians quickly recognized that the LMA could provide effective ventilation when all methods to ventilate via a facemask had failed. In addition to rescue ventilation, EGAs can facilitate tracheal intubation and extubation in patients with a challenging airway.

Back to Top | Article Outline
One-Step Blind Intubation

When the cLMA is perfectly positioned, the aperture lies against the glottic inlet, making blind tracheal intubation possible. Heath and Allagain reported a 90% success rate for passing a 6-mm endotracheal tube blindly through a cLMA in 50 elective surgical patients.108 When cricoid pressure was used in another 50 patients, the success rate decreased to 56%. The small internal diameter of the cLMA accommodates a small, cuffed endotracheal tube. Removing an LMA over a 6-mm endotracheal tube, however, is challenging. There may insufficient length to pass the cuff of the endotracheal tube beyond the larynx into the trachea. To overcome this problem, intubation using the much longer nasal RAE (Covidien-Nellcor, Boulder, CO) tracheal tube has been described.109 Elective, blind tracheal intubation through the cLMA or other EGAs not specifically designed for this technique is not recommended because of the low success rate and possibility of trauma.

Larger endotracheal tubes can be used with the air-Q or eLMA because both have shafts with larger internal diameters and a removable endotracheal tube adapter. The Aura-i also has a larger lumen accommodating up to an 8.0-mm endotracheal tube, but the manufacturer does not recommend blind intubation techniques using the device.

Back to Top | Article Outline
Two-Step Bougie-Aided Blind Intubation

A hollow bougie or tube changer can be passed blindly into the trachea through the EGA. Correct tracheal placement of the tube changer into the trachea is confirmed by measuring end-tidal carbon dioxide. The EGA is then removed and the tracheal tube is railroaded over the tube changer into the trachea. Potential disadvantages of this technique include the disruption of ventilation after removal of the EGA and failure to pass the tube over the tube changer. If the EGA is not positioned correctly, it is difficult to introduce the tube changer into the trachea via the EGA.

Back to Top | Article Outline
One-Step Fiberoptic-Aided Intubation

Fiberoptic-assisted tracheal intubation through the cLMA was first reported in adults in 1991 and in children in 1994.110,111 Johnson and Sims achieved fiberoptic intubation through a cLMA placed under topical anesthesia in an infant with Goldenhar's syndrome.112 In adults, the 6.0-mm cuffed endotracheal tube often used through the cLMA is 28-cm long; a size-4 cLMA is 19 cm long. The mean distance of the LMA grille to the vocal cords is 3.5 cm, leaving only 4.5 cm of tube beyond the vocal cords. The chance of inflating the cuff of the endotracheal tube in the larynx rather than in the trachea is thereby increased, increasing the possibility of laryngeal nerve damage. Removing the 15-mm adapter from the cLMA before intubation shortens its length by 18 mm and allows deeper placement of the tracheal tube. Other options to counter this problem include selection of a longer tube, such as a nasal RAE tube. The iLMA is designed for blind intubation with a long tracheal tube; however, 3% to 4% of the time, poor alignment of the epiglottis elevating bar interferes with blind intubation. Fiberoptic guidance can increase the success rate to 100%.47

Back to Top | Article Outline
Two-Step Fiberoptic-Aided Intubation

Two-step fiberoptic EGA-assisted intubation uses an Aintree intubating catheter (Cook Medical, Bloomington, IN), which is inserted over a fiberoptic scope that is directed through the EGA into the trachea. The fiberoptic bronchoscope and EGA are then removed, leaving only the Aintree catheter in the trachea, which serves as a guide for tracheal tube advancement into the trachea. Oxygen delivery can be continued during placement of the Aintree catheter into the trachea, and may increase the safety of the technique.

Back to Top | Article Outline
Three-Step Fiberoptic-Aided Intubation

During 3-step fiberoptic-aided intubation, the fiberoptic bronchoscope is passed through the EGA into the trachea. A guidewire is then passed through the suction channel of the bronchoscope into the trachea. The fiberoptic bronchoscope is removed, leaving the guidewire inside the trachea. An airway exchange catheter is passed over the guidewire into the trachea, the EGA is removed, and the tracheal tube is advanced over the catheter into the trachea.113

Back to Top | Article Outline
Tracheal Extubation: The EGA as a Bridge to Extubation

Upper airway obstruction, hypoventilation, and hypoxemia are common after tracheal extubation but before return of airway reflexes during emergence from general anesthesia. Conversely, an “awake” extubation in which the patient has regained full airway reflexes after emergence from general anesthesia can result in severe coughing, hypertension, and tachycardia. EGA-assisted tracheal extubation prevents upper airway obstruction, especially in obese patients, and minimizes hemodynamic changes that may be seen during the awake extubation technique. The cLMA, pLMA, or other EGAs can be used as an orolaryngeal airway to facilitate a smooth transition from deep tracheal anesthesia to awake extubation.114,115 The tracheal tube is exchanged for a cLMA or pLMA while the patient is deeply anesthetized, or even while the tracheal tube is still in place. The establishment of the EGA before extubation allows a timely exchange of airway devices as the tracheal tube is removed. The EGA then provides a stable and patent airway during emergence from anesthesia, which is helpful in situations where manipulation of the patient's head and neck or pressure from facemask application might harm the patient or the surgical result.116

Back to Top | Article Outline

CONCLUSION

Introduction of the cLMA >20 years ago marked a new era in airway management. Since then, several new LMAs and a number of other EGAs have been introduced. A difficult airway often makes mask ventilation and tracheal intubation problematic. EGA devices have the potential to improve ventilation and often assist in subsequent tracheal intubation. Ventilation via an EGA when intubation and facemask ventilation have failed may be a lifesaving procedure. These new devices provided new methods for managing the airway and were enthusiastically received by anesthesiologists and other practitioners, encouraging further development and introduction of other EGA designs. The use of EGAs in anesthesia-based airway management is well established; their use for airway management outside the OR is still evolving, and novel applications provide flexibility for the anesthesiologist or proceduralist who needs to access the airway or digestive tract. The use of EGAs in formerly contraindicated patients, procedures, and locations continues to challenge conventional methods of airway management. Proper patient screening, appropriate EGA size selection, attention to appropriate placement and positioning, atraumatic insertion, and maintenance of an intracuff pressure no higher than 60 cm H2O (44 mm Hg) enhance the safety and efficacy of EGAs. There is no doubt that continued advances in both design and application of EGAs will continue to improve perioperative care, airway management, and patient safety. Clinicians will continue to be challenged by ever-increasing numbers of devices and competing claims from manufacturers. Ongoing research will be needed to evaluate EGA devices and their application to determine the best strategies for routine and difficult airway management in a variety of clinical settings.

Back to Top | Article Outline

DISCLOSURES

Name: Michael R. Hernandez, MD.

Attestation: Primary author.

Name: P. Allan Klock, Jr., MD.

Attestation: Secondary author.

Conflicts of Interest: Unpaid member of advisory board for Ambu corporation. On October 18, 2010 (long after commencing work on the manuscript), P. Allan Klock, Jr. was approached by Ambu corporation and asked to chair an airway management advisory board for 2 years starting in February 2011. There will be a small honorarium given to those who participate in our twice-yearly meetings. P. Allan Klock Jr. has not yet received any compensation from Ambu, and has have no, and does not plan on owning, stock options in Ambu. His personal compensation and financial status will not vary regardless of the financial performance of the company.

Name: Adranik Ovassapian, MD.

Attestation: Senior author.

Conflicts of Interest: Consultant for LMA Company. Dr. Ovassapian is deceased, and it is difficult to know his prior industry involvement. He did serve as a consultant to the LMA Company in the past. His official disclosure on file with the University of Chicago Provost's Office disclosed no conflicts.

This manuscript was handled by: Sorin J. Brull, MD.

Back to Top | Article Outline
ACKNOWLEDGMENTS

Michael R. Hernandez and P. Allan Klock, Jr. would like to acknowledge the contribution of Andranik “Andy” Ovassapian, MD (1936–2010) to the generation of this manuscript and the profession of anesthesiology. Dr. Ovassapian was a contributing author of this review article at the time of his death in June 2010.

A leader in advanced airway management and fiberoptic intubation, Dr. Ovassapian was a world-renowned clinician, researcher, and educator. Born in Arak, Iran, Dr. Ovassapian received his medical degree from Pahlavi University in Shiraz, Iran, and moved to the United States in 1963 to complete his residency at the Hospital of the University of Pennsylvania. He returned to Iran to teach at Pahlavi University for 6 years before accepting a position at Northwestern University in 1974. He joined the University of Chicago in 1998.

Dr. Ovassapian taught fiberoptic intubation and advanced airway techniques to thousands of doctors and helped establish airway training centers and courses around the world. In 1995, Dr. Ovassapian founded the Society for Airway Management, a multispecialty organization dedicated to advancing all aspects of airway management. He was a valued and respected colleague who will be sorely missed.

a Ferson DZ, Chi L, Zambare S, Brown D. The effectiveness of the LMA Supreme in patients with normal and difficult-to-manage airways. (abstract) Anesthesiology 2007;107:A592. Cited Here...

b Genzwuerker HV, Hinkelbein J, Krivosic-Horber R, et al. Performance of the new single-use Ambu laryngeal mask in different head positions. (abstract) Anesthesiology 2004;101:A1590. Cited Here...

c Klein MT, Jones J: Utility of the intubating laryngeal airway: report of an observational study. (abstract) Anesthesiology 2005;103:A846. Cited Here...

Back to Top | Article Outline

REFERENCES

1. Brimacombe J. A proposed classification system for extraglottic airway devices. Anesthesiology 2004;101:559

2. Brain AI. The development of the laryngeal mask—a brief history of the invention, early clinical studies, and experimental work from which the laryngeal mask evolved. Eur J Anaesthesiol Suppl 1991;4:5–17

3. Benumof JL. Laryngeal mask airway and the ASA difficult airway algorithm. Anesthesiology 1996;84:686–99

4. Henderson JJ, Popat MT, Latto IP, Pearce AC. Difficult Airway Society guidelines for management of the unanticipated difficult intubation. Anaesthesia 2004;59:675–94

5. Brimacombe JR. Seal with the respiratory and gastrointestinal tracts. In: Laryngeal Mask Anesthesia: Principles and Practice, 2nd ed. Philadelphia: W.B. Saunders, 2005: 137–52

6. Keller C, Brimacombe JR, Keller K, Morris R. Comparison of four methods for assessing airway sealing pressure with the laryngeal mask airway in adult patients. Br J Anaesth 1999;82:286–7

7. Lopez-Gil M, Brimacombe J, Keller C. A comparison of four methods for assessing oropharyngeal leak pressure with the laryngeal mask airway in paediatric patients. Paediatr Anaesth 2001;11:319–21

8. Lumb AB, Wrigley MW. The effect of nitrous oxide on laryngeal mask cuff pressure. In vitro and in vivo studies. Anaesthesia 1992;47:320–3

9. Strang TI. Does the laryngeal mask airway compromise cricoid pressure? Anaesthesia 1992; 47: 829–31

10. Li CW, Xue FS, Xu YC, Liu Y, Mao P, Liu KP, Yang QY, Zhang GH, Sun HT Cricoid pressure impedes insertion of, and ventilation through, the proseal laryngeal mask airway in anesthetized, paralyzed patients. Anesth Analg 2007;104:1195–8

11. Rowbottom SJ, Simpson DL, Grubb D. The laryngeal mask airway in children. A fiberoptic assessment of positioning.. Anaesthesia 1991;46:489–91

12. Brimacombe J. The advantages of the LMA over the tracheal tube or facemask: a meta-analysis. Can J Anaesth 1995;42:1017–23

13. Tanaka A, Isono S, Ishikawa T, Sato J, Nishino T. Laryngeal resistance before and after minor surgery: endotracheal tube versus laryngeal mask airway. Anesthesiology 2003;99:252–8

14. Brimacombe JR. Problems. In: Laryngeal Mask Anesthesia: Principles and Practice, 2nd ed. Philadelphia: W.B. Saunders, 2005: 555–6

15. Maltby JR, Loken RG, Watson NC. The laryngeal mask airway: clinical appraisal in 250 patients. Can J Anaesth 1990;37:509–13

16. Abrishami A, Zilberman P, Chung F. Brief review: airway rescue with insertion of laryngeal mask airway devices with patients in the prone position. Can J Anaesth 2010;57:1014–20

17. Brimacombe JR, Wenzel V, Keller C. The ProSeal laryngeal mask airway in prone patients: a retrospective audit of 245 patients. Anaesth Intensive Care 2007;35:222–225

18. Sharma V, Verghese C, McKenna PJ. Prospective audit on the use of the LMA-Supreme™ for airway management of adult patients undergoing elective orthopaedic surgery in prone position. Br J Anaesth 2010;105:228–32

19. Lopez AM, Valero R, Brimacombe J. Insertion and use of LMA Supreme™ in the prone position. Anaesthesia 2010;65:154–7

20. Lim Y, Goel S, Brimacombe JR. The ProSeal™ laryngeal mask airway is an effective alternative to laryngoscope-guided tracheal intubation for gynaecological laparoscopy. Anaesth Intensive Care 2007;35:52–6

21. Sinha A, Sharma B, Sood J. ProSeal™ as an alternative to endotracheal intubation in pediatric laparoscopy. Paediatr Anaesth 2007;17:327–32

22. Shah EF, Allen JG, Greatorex RA. Use of the laryngeal mask airway in thyroid and parathyroid surgery as an aid to the identification and preservation of the recurrent laryngeal nerves. Ann R Coll Surg Engl 2001;83:315–8

23. Han TH, Brimacombe J, Lee EJ, Yang HS. The laryngeal mask airway is effective (and probably safe) in selected healthy parturients for elective Cesarean section: a prospective study of 1067 cases. Can J Anaesth 2001;48:1117–21

24. Dhonneur G, Ndoko SK, Yavchitz A, Foucrier A, Fessenmeyer C, Pollian C, Combes X, Tual L. Tracheal intubation of morbidly obese patients: LMA CTrach vs direct laryngoscopy. Br J Anaesth 2006;97:742–5

25. Di lorio C, Cafiero T, Varriale P, Spatola R, Mannelli R, Di Minno RM. Prolonged use of the ProSeal laryngeal mask in ICU: a case report. Eur J Anaesthesiol 2006;23:979–80

26. Keller C, Brimacombe J, Bittersohl J, Lirk P, von Goedecke A. Aspiration and the laryngeal mask airway: three cases and a review of the literature. Br J Anaesth 2004;93:579–82

27. Asai T. Editorial II: Who is at increased risk of pulmonary aspiration? Br J Anaesth 2004;93:497–500

28. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during the perioperative period. Anesthesiology 1993;78:56–62

29. Wahlen BM, Heinrichs W, Latorre F. Gastric insufflation pressure, air leakage and respiratory mechanics in the use of the laryngeal mask airway (LMAU) in children. Paediatr Anaesth 2004;14:313–7

30. Marjot R. Pressure exerted by the laryngeal mask airway cuff upon the pharyngeal mucosa. Br J Anaesth 1993;70:25–9

31. von Ungern-Sternberg BS, Erb TO, Chambers NA, Heaney M. Laryngeal mask airways—to inflate or to deflate after insertion? Paediatr Anaesth 2009;19:837–43

32. King C, Street MK. Twelfth cranial nerve paralysis following use of the laryngeal mask airway. Anaesthesia 1994;49:786–7

33. Nagai K, Sakuramoto C, Goto F. Unilateral hypoglossal nerve paralysis following the use of the laryngeal mask airway. Anaesthesia 1994;49:603–4

34. Inomata S, Nishikawa T, Suza A, Yamashita S. Transient bilateral vocal cord paralysis after insertion of a laryngeal mask airway. Anesthesiology 1995;82:787–8

35. Shimoda O, Yoshitake A. Stylet for reinforced laryngeal mask airway. Anaesthesia 2002;57:1140–1

36. Brimacombe J, Keller C. Comparison of the flexible and standard laryngeal mask airways. Can J Anaesth 1999;46:558–63

37. Brain AI, Verghese C, Strube PJ. The LMA ProSeal—a laryngeal mask with an oesophageal vent. Br J Anaesth 2000;84: 650–4

38. Keller C, Brimacombe J, Kleinsasser A, Loeckinger A. Does the ProSeal laryngeal mask airway prevent aspiration of regurgitated fluid? Anesth Analg 2000;91:1017–20

39. Brimacombe J, Keller C, Fullekrug B, Agrò F, Rosenblatt W, Dierdorf SF, Garcia de Lucas E, Capdevilla X, Brimacombe N. A multicenter study comparing the ProSeal and classic laryngeal mask airway in anesthetized, nonparalyzed patients. Anesthesiology 2002;96:289–95

40. Natalini G, Franceschetti ME, Pantelidi MT, Rosano A, Lanza G, Bernardini A. Comparison of the standard laryngeal mask airway and the ProSeal laryngeal mask airway in obese patients. Br J Anaesth 2003;90:323–6

41. Drolet P, Girard M. An aid to correct positioning of the ProSeal laryngeal mask (Letter). Can J Anaesth 2001;48:718–9

42. Brimacombe J, Keller C, Judd DV. Gum elastic bougie-guided insertion of the ProSeal™ laryngeal mask airway is superior to the digital and introducer tool techniques. Anesthesiology 2004;100:25–9

43. O'Connor CJ Jr, Stix MS. Assessing ProSeal laryngeal mask positioning: the suprasternal notch test. Anesth Analg 2002;94:1374–5

44. O'Connor CJ Jr, Stix MS. Bubble solution diagnoses Proseal insertion into the glottis (letter). Anesth Analg 2002;94:1671–2

45. Brimacombe J, Keller C, Berry A, Mitchell S. Assessing ProSeal laryngeal mask positioning: the suprasternal notch test (reply). Anesth Analg 2002;94:1375

46. Baskett PJ, Parr MJ, Nolan JP. The intubating laryngeal mask. Results of a multicentre trial with experience of 500 cases.. Anaesthesia 1998;53:1174–9

47. Ferson DZ, Rosenblatt WH, Johansen MJ, Osborn I, Ovassapian A. Use of the intubating LMA-Fastrach in 254 patients with difficult-to-manage airways. Anesthesiology 2001;95: 1175–81

48. Frappier J, Guenoun T, Jois D, Philippe H, Aka E, Cadi P, Silleran-Chassany J, Safran D. Airway management using the intubating laryngeal mask airway for the morbidly obese patient. Anesth Analg 2003;96:1510–5

49. Kihara S, Yaguchi Y, Brimacombe J, Watanabe S, Taguchi N. Hosoyan. Intubating laryngeal mask airway size selection: A randomized triple crossover study in paralyzed, anesthetized male and female adult patients. Anesth Analg 2002;94:1023–7

50. Liu EH, Goy RW, Chen EG. An evaluation of poor LMA CTrach view with fibreoptic laryngoscope and the effectiveness of corrective measures. Br J Anaesth 2006;97:878–82

51. Kundra P, Sujata N, Ravishankar M. Conventional tracheal tubes for intubation through the intubating laryngeal mask airway. Anesth Analg 2005;100:284–8

52. Joo HS, Rose DK. The intubating laryngeal mask airway with and without fiberoptic guidance. Anesth Analg 1999;88:662–6

53. Lu PP, Yang CH, Ho AC, Shyr MH. The intubating LMA: a comparison of insertion techniques with conventional tracheal tubes. Can J Anaesth 2000;47:849–53

54. Timmermann A, Cremer S, Eich C, Kazmaier S, Bräuer A, Graf BM, Russo SG. Prospective clinical and fiberoptic evaluation of the Supreme laryngeal mask airway. Anesthesiology 2009;110:262–5

55. Hagberg CA, Agro FE, Cook TM, Reed AP. New generation supraglottic ventilatory devices. In: Benumof's Airway Management, 2nd ed., Hagberg CA (ed.). Philadelphia: Mosby Elsevier, 2007;502–31

56. Hagberg CA, Jensen FC, Genzwuerker HV, Krivosic-Horber R, Schmitz BU, Hinkelbein J, Contzen M, Menu H, Bourzoufi K. A multicenter study of the Ambu laryngeal mask in nonparalyzed anesthetized patients. Anesth Analg 2005;101: 1862–6

57. Francksen H, Bein B, Cavus E, Renner J, Scholz J, Steinfath M, Tonner PH, Doerges V. Comparison of LMA Unique, Ambu laryngeal mask and Soft Seal laryngeal mask during routine surgical procedures. Eur J Anaesthesiol 2007;24:134–40

58. Gaitini L, Yanovski B, Somri M, Vaida S, Riad T, Alfery D. A comparison between the PLA Cobra and the Laryngeal Mask Airway Unique during spontaneous ventilation: a randomized prospective study. Anesth Analg 2006;102:631–6

59. Akça O, Wadhwa A, Sengupta P, Durrani J, Hanni K, Wenke M, Yücel Y, Lenhardt R, Doufas AG, Sessler DI. The new perilaryngeal airway (CobraPLA) is as efficient as the laryngeal mask airway (LMA) but provides better airway sealing pressures. Anesth Analg 2004;99:272–8

60. Agro F, Barzoi G, Galli B. The CobraPLA in 110 anaesthetized and paralysed patients: what size to choose (Letter)? Br J Anaesth 2004;92:777–8

61. Gaitini LA, Vaida SJ, Mostafa S, Yanovski B, Croitoru M, Capdevila MD, Sabo E, Ben-David B, Benumof J. The Combitube in elective surgery: a report of 200 cases. Anesthesiology 2001;94:79–82

62. Agro F, Frass M, Benumof JL, Krafft P. Current status of the Combitube a review of the literature. J Clin Anesth 2002;14:307–14

63. Urtubia RM, Aguila CM, Cumsille MA. Combitube: a study for proper use. Anesth Analg 2000;90:958–62

64. Krafft P, Röggla M, Fridrich P, Locker GJ, Frass M, Benumof JL. Bronchoscopy via a re-designed Combitube in the esophageal position. A clinical evaluation.. Anesthesiology 1997;86: 1041–5

65. Vezina M-C, Trepanier CA, Nicole PC, Lessard MR. Complications associated with the Esophageal-Tracheal Combitube in the pre-hospital setting. Can J Anaesth 2007;54:124–8

66. Kikuchi T, Kamiya Y, Ohtsuka T, Miki T, Goto T. Randomized prospective study comparing the laryngeal tube suction ii with the ProSeal™ laryngeal mask airway in anesthetized and paralyzed patients. Anesthesiology 2008;109:54–60

67. Hagberg CA, Bogomolny Y, Gilmore C, Gibson V, Kaitner M, Khurana S. An evaluation of the insertion and function of a new supraglottic airway device, the King LT, during spontaneous ventilation. Anesth Analg 2006;102:621–5

68. Asai T, Murao K, Shingu K, Noguchi T, Koga K. Efficacy of the laryngeal tube during intermittent positive-pressure ventilation. Anaesthesia 2000;55:1099–102

69. Asai T, Matsumoto S, Shingu K, Noguchi T, Koga K. Use of the laryngeal tube after failed insertion of the laryngeal mask airway. Anaesthesia 2005;60:625–6

70. Brimacombe J, Keller C, Brimacombe L. A comparison of the laryngeal mask airway ProSeal and the laryngeal tube airway in paralyzed anesthetized adult patients undergoing pressure-controlled ventilation. Anesth Analg 2002;95:770–6

71. Cook TM, Cranshaw J. Randomized crossover comparison of ProSeal® Laryngeal Mask Airway with Laryngeal Tube Sonda® during anaesthesia with controlled ventilation. Br J Anaesth 2005;95:261–6

72. Shin WJ, Cheong YS, Yang HS, Nishiyama T. The supraglottic airway I-gel in comparison with ProSeal laryngeal mask airway and classic laryngeal mask airway in anaesthetized patients. Eur J Anaesthesiol 2010;27:598–601

73. Miller DM, Light D. Laboratory and clinical comparisons of the Streamlined Liner of the Pharynx Airway (SLIPA) with the laryngeal mask airway. Anaesthesia 2003;58:136–42

74. Lange M, Smul T, Zimmermann P, Kohlenberger R, Roewer N, Kehl F. Effectiveness and patient comfort of the novel streamlined pharynx airway liner (SLIPA) compared with the conventional laryngeal mask airway in ophthalmic surgery. Anesth Analg 2007;104:431–4

75. Miller DM, Camporota L. Advantages of ProSeal and SLIPA airways over tracheal tubes for gynecological laparoscopies. Can J Anaesth 2006;53:188–93

76. Greene MK, Roden R, Hinchley G. the laryngeal mask airway. Two cases of prehospital trauma care. Anaesthesia 1992;47: 688–9

77. Pennant JH, Walker MB. Comparison of the endotracheal tube and laryngeal mask in airway management by paramedical personnel. Anesth Analg 1992;74:531–4

78. Stone B, Leach AB, Alexander CA. The use of the laryngeal mask airway by nurses during cardiopulmonary resuscitation—results of a multicentre trial. Anaesthesia 1994;49:3–7

79. Blostein PA, Koestner AJ, Hoak S. Failed rapid sequence intubation in trauma patients: esophageal tracheal Combitube is a useful adjunct. J Trauma 1998;44:534–7

80. Schalk R, Byhahn C, Fausel F, Egner A, Oberndorfer D, Walcher F, Latasch L. Out-of-hospital airway management by paramedics and emergency physicians using laryngeal tubes. Resuscitation 2010;81:323–6

81. Stone BJ, Chantler PJ, Baskett PJ. The incidence of regurgitation during cardiopulmonary resuscitation: a comparison between the bag valve mask and laryngeal mask airway. Resuscitation 1998;38:3–6

82. Frass M, Frenzer R, Rauscha F, Schuster E, Glogar D. Ventilation with the esophageal tracheal Combitube in cardiopulmonary resuscitation: promptness and effectiveness. Chest 1988;93:781

83. Frass M, Frenzer R, Mayer G, Popovic R, Leithner C. Mechanical ventilation with the esophageal tracheal Combitube (ETC) in the intensive care unit. Arch Emerg Med 1987;4:219–25

84. Wheeler M, Cote CJ, Todres ID. The Pediatric Airway. In: Cote CJ ed. A Practice of Anesthesia for Infants and Children. 4th ed. Philadelphia: Saunders Elsevier, 2009: 237–41

85. Mason DG, Bingham RM. The laryngeal mask airway in children. Anaesthesia 1990;45:760–3

86. Dubreuil M, Laffon M, Plaud B, Penon C, Ecoffey C. Complications and fiberoptic assessment of size 1 laryngeal mask airway. Anesth Analg 1993;76:527–9

87. Lopez-Gil M, Brimacombe J, Alvarez M. Safety and efficacy of the laryngeal mask airway. A prospective survey of 1400 children.. Anaesthesia 1996;51:969–72

88. Chen L, Hsiao AL. Randomized trial of endotracheal tube versus laryngeal mask airway in simulated prehospital pediatric arrest. Pediatrics 2008;122:e294–7

89. Trevisanuto D, Verghese C, Doglioni N, Ferrarese P, Zanardo V. Laryngeal mask airway for the interhospital transport of neonates. Pediatrics 2005;115;e109–11

90. Ong M, Chambers NA, Hullet B, Erb TO, von Ungern-Sternberg BS. Laryngeal mask airway and tracheal tube cuff pressures in children: are clinical endpoints valuable for guiding inflation? Anaesthesia 2008;63:738–44

91. Wong JG, Heaney M, Chambers NA, Erb TO, von Ungern-Sternberg BS. Impact of laryngeal mask airway cuff pressures on the incidence of sore throat in children. Paediatr Anaesth 2009;19:464–9

92. Seet E, Yousaf F, Smita G, Subramanyam R, Wong DT, Chung F. Use of manometry for laryngeal mask airway reduces postoperative pharyngolaryngeal adverse events. Anesthesiology 2010;112:652–7

93. Goldmann K, Roettger C, Wulf H. The size 1 1/2 ProSeal laryngeal mask airway in infants: a randomized, crossover investigation with the Classic laryngeal mask airway. Anesth Analg 2006;102:405–10

94. Lardner DR, Cox RG, Ewen A, Dickinson D. Comparison of laryngeal mask airway (LMA)-Proseal and the LMA-Classic in ventilated children receiving neuromuscular blockade. Can J Anaesth 2008;55:29–35

95. Wheeler M. ProSeal laryngeal mask airway in 120 pediatric surgical patients: a prospective evaluation of characteristics and performance. Paediatr Anaesth 2006;16:297–301

96. Grebenik CR, Ferguson C, White A. The laryngeal mask airway in pediatric radiotherapy. Anesthesiology 1990;72:474–7

97. Williams PJ, Bailey PM. Comparison of the reinforced laryngeal mask airway and tracheal intubation for adenotonsillectomy. Br J Anaesth 1993;70:30–3

98. White MC, Cook TM, Stoddart PA. A critique of elective pediatric supraglottic airway devices. Paediatr Anaesth 2009;19:55–65

99. Polaner DM, Ahuja D, Zuk J, Pan Z. Video assessment of supraglottic airway orientation through the perilaryngeal airway in pediatric patients. Anesth Analg 2006;102:1685–8

100. Gaitini L, Carmi N, Yanovski B, Tome R, Resnikov I, Gankin I, Somri M, Alfery D. Comparison of the CobraPLA (Cobra Perilaryngeal Airway) and the Laryngeal Mask Airway Unique in children under pressure controlled ventilation. Paediatr Anaesth 2008;18:313–9

101. Szmuk P, Ghelber O, Matuszczak M, Rabb MF, Ezri T, Sessler DI. A prospective, randomized comparison of cobra perilaryngeal airway and laryngeal mask airway unique in pediatric patients. Anesth Analg 2008;107:1523–30

102. Passariello M, Almenrader N, Coccetti B, Haiberger R, Pietropaoli P. Insertion characteristics, sealing pressure and fiberoptic positioning of CobraPLA in children. Paediatr Anaesth 2007;17:977–82

103. Beylacq L, Bordes M, Semjen F, Cros AM. The i-gel, a single-use supraglottic airway device with a non-inflatable cuff and an esophageal vent: An observational study in children. Acta Anaesthesiol Scand 2009;53:376–9

104. Scheller B, Schalk R, Byhahn C, Peter N, L'Allemand N, Kessler P, Meininger D. Laryngeal tube suction II for difficult airway management in neonates and small infants. Resuscitation 2009;80:805–10

105. Genzwuerker HV, Fritz A, Hinkelbein J, Finteis T, Schlaefer A, Schaeffer M, Thil E, Rapp HJ. Prospective, randomized comparison of laryngeal tube and laryngeal mask airway in pediatric patients. Paediatr Anaesth 2006;16:1251–6

106. Jagannathan N, Kho MF, Kozlowksi RJ, Sohn LE, Siddiqui A, Wong DT. Retrospective audit of the air-Q intubating laryngeal airway as a conduit for tracheal intubation in pediatric patients with a difficult airway. Paediatr Anaesth 2011;21:422–7

107. Jagannathan N, Kozlowski RJ, Sohn LE, Langen KE, Roth AG, Mukherji II, Kho MF, Suresh S. A clinical evaluation of the intubating laryngeal airway as a conduit for tracheal intubation in children. Anesth Analg 2011;112:176–82

108. Heath ML, Allagain J. Intubation through the laryngeal mask. A technique for unexpected difficult intubation.. Anaesthesia 1991;46:545–8

109. Alfery DD. Laryngeal mask airway and the ASA difficult airway algorithm (Letter). Anesthesiology 1996;85:685

110. Hasham F, Kumar CM, Lawler PG. The use of the laryngeal mask airway to assist fibreoptic orotracheal intubation. Anaesthesia 1991;46:891

111. Hasan MA, Black AE. A new technique for fibreoptic intubation in children. Anaesthsia 1994;49:1031–3

112. Johnson CM, Sims C. Awake fibreoptic intubation via a laryngeal mask in an infant with Goldenhar's syndrome. Anaesth Intensive Care 1994;22:194–7

113. Sartore DM, Kojima RK. Laryngeal mask airway-assisted, wire-guided fiberoptic tracheal intubation. Anesthesiology 1994;81:150–1

114. Koga K, Asai T, Vaughan RS, Latto IP. Respiratory complications associated with tracheal extubation: timing of tracheal extubation and use of the laryngeal mask during emergence from anesthesia. Anaesthesia 1998;53:540–4

115. Dob DP, Shannon CN, Bailey PM. Efficacy and safety of the laryngeal mask airway vs Guedel airway following tracheal extubation. Can J Anaesth 1999;46:179–81

116. Asai T, Shingu K. Use of the laryngeal mask during emergence from anesthesia in a patient with an unstable neck. Anesth Analg 1999;88:469–70

117. Nussbaum E, Zagnoev M. Pediatric fiberoptic bronchoscopy with a laryngeal mask airway. Chest 2001;120:614–6

118. Lopez-Gil M, Brimacombe J, Diaz-reganon G. Anesthesia for paediatric gastroscopy: a study comparing the ProSeal laryngeal mask airway with nasal cannulae. Paediatr Anaesth 2006;16:1032–5

119. Fraser J, Hill C, McDonald D, Jones C, Petros A. The use of the laryngeal mask airway for the inter-hospital transport of infants with type 3 laryngo-tracheal-oesophageal clefts. Intensive Care Med 1999;25:714–6

Supplemental Digital Content

Back to Top | Article Outline

© 2012 International Anesthesia Research Society

Login

Become a Society Member